CHESTGuidelines & Topic CollectionsPulmonary Vascular Disease

Pulmonary Vascular Disease

In brief: What’s new and notable in pulmonary vascular disease

Explore research into the effects of exercise training with patients with persistent dyspnea, infographics on decreasing pulmonary embolism-related mortality, and videos on pulmonary hypertension.


Advertisement

On this page

RESOURCES

Clinician education resources

NEWS

News and notes

EDUCATION

Simulation courses

Advertisement

Pulmonary vascular disease resources for patients and clinicians

Clinician education resources to explore

PEER-TO-PEER LEARNING
PEER-TO-PEER LEARNING

Introduction to Pulmonary Hypertension

Review new definitions of pulmonary hypertension and more in part one of this peer-created video series. Watch all the videos in this series.

DATA Trends
PULMONOLOGY DATA TRENDS 2023

Decreasing Pulmonary Embolism-Related Mortality

Proper risk stratification is crucial to identify the best approach for each patient with pulmonary embolism.

Antithrombotic Therapy in COVID-19
GUIDELINE

Antithrombotic Therapy in COVID-19

This guideline provides recommendations for managing four arterial (pro)thrombotic medical conditions in patients with COVID-19.

Pulmonary vascular disease news and notes

Follow the latest pulmonary vascular disease news

CHEST DAILY NEWS

Pulmonary experts discuss risk stratification, treatment of intermediate-risk PE in case-based session
Audience members helped advance a step-by-step exploration of intermediate-risk pulmonary embolism (PE) that blended a fictional case study with quiz questions and an expert panel discussion.

CARDIOVASCULAR MEDICINE AND SURGERY SECTION

Sepsis-induced cardiomyopathy: Is it time to establish a standard of care?
No universal definition of sepsis-induced cardiomyopathy exists, making diagnosis and evaluation of therapeutic options difficult.

PULMONARY VASCULAR DISEASE SECTION

The STELLAR Travel to BMPR2-based therapies for pulmonary arterial hypertension
The recent STELLAR trial was designed to evaluate patients with pulmonary arterial hypertension receiving stable vasodilator therapy after treatment with sotatercept.

PODCAST

Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19?
The authors of a recent journal article debate the potential benefits and risks of administering therapeutic heparin to patients with COVID-19.

Build your pulmonary vascular disease expertise with CHEST education

CHEST SEEK™ Education

Written and peer reviewed by renowned experts in the critical care, pulmonary, and sleep medicine fields, the online CHEST SEEK Library and print publications include case-based questions and detailed rationales to stimulate and challenge your clinical thought process; help you prepare for certification or recertification exams; and allow you to obtain CME credit, MOC points, and CE hours.


CHEST SEEK LIBRARY

Access hundreds of critical care, pulmonary, and sleep medicine questions.

PURCHASE NOW »

Join the Community

If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.

JOIN NOW »